Dr. Christian Policard is the chairman and founding partner of Biotech Developpement Conseils. He has served as executive vice-president of Business Development at the Pasteur Institute, a member of the international executive committee of Sanofi-Synthelabo and board member of biotechnology and pharmaceutical companies in France, Israel, the United Kingdom and the United States. He specializes in the fields of vaccines and diagnostics.
-
Christian Policard, PhDBiotech Developpement Conseils(33) 1 78 99 43 99 -
Joaquim Trias Puig-Sureda, PhDDr. Joaquim Trias Puig-Sureda is one of the top names in the American biotech sector. Born in Barcelona, his entrepreneuring spirit took him to the heart of Silicon Valley nearly 20 years ago. He has helped found companies like Microcide Pharmaceuticals, Vicuron (acquired by Pfizer), Peninsula (bought by Johnson&Johnson), Anthera and Tetraphase. At Microcide, he started up numerous programs to research infectious disease. At Vicuron, he served as vice-president of Drug Discovery and participated in clinical development programs, which led the company to discover new antibiotics that have moved into the clinical phase. He is currently president of the venture capital and bio-pharmaceutical consulting firm JTPS.
960 Sequoia Ave, Millbrae, CA-94030 (USA)(1) 650 8674755 -
Ludwig Weiss, PhDDr. Ludwig Weiss has over 15 years experience as the general director of different German biotechnology and pharmaceutical companies. He focuses on strategic alliances and business development. Before moving into the business world, he acquired a solid scientific foundation leading a work group at the Max-Planck-Institute of Biochemistry in Munich.
SciXess GmbH • PO Box 1121 • D-86425 Kissing (Germany)(49) 0 176 23570247 -
Martin Austin, PhDHe is the managing director of TransformRx GMBH, partner at Marram Advisors and board member at RSA AG. He has led international projects in the pharmaceutical and biotechnology fields for clients in Switzerland, the United Kingdom, France, Germany, Belgium, Sweden, the United States and Denmark. He is a business development expert. In 2008, he published the book entitled Business Development for the Biotechnology and Pharmaceutical Industry (Gower).
TransformRx GmbH • St Jakobs Strasse 30 • 4052 Basel (Switerland)(41) 61 283 4460 -
Ms. Nicole Rieunier-BurleMs. Rieunier-Burle has dedicated the majority of her career to the life sciences industry as legal council for Sanofi, general advisor at Sanofi-Beauté-Yves Saint Laurent and director of Legal Affairs at the Pasteur Institute. She specializes in mergers, acquisitions, joint ventures, contractual negotiations and managing litigation related to intellectual property, on an international level.
Biotech Developpement Conseils(33) 1 78 99 43 99 -
Nancy Levy, PhD
Dr. Levy has a solid reputation thanks to her ample experience in the biopharmaceutical field. She has worked in all types of companies, from start-ups to well-established enterprises, as well as with venture capitalists and investment bankers. She specializes in business strategy, business development, business management and patents in both the United States and Europe.
BioHealth Management, LLC • 1548 Commonwealth Ave. • West Newton, MA 02465 (Boston, USA)(1) 617 6802010
Biocat has no contractual relationship with the advisors listed on this page. Biocat offers and updates the professional profiles, which are solely informational in nature. People interested in being included in the list must meet the following requirements: carry out their activities outside of the BioRegion of Catalonia; be an individual, not a legal entity; and have more ten years demonstrable experience in business development, intellectual property strategies, scientific market strategies, or as a non-executive general director.
Send application to join the list of advisorsQuestions: innovacio@biocat.cat
